Literature DB >> 2012264

Naturally acquired circumsporozoite antibodies and their role in protection in endemic falciparum and vivax malaria.

C Wongsrichanalai1, H K Webster, B Permpanich, N Chuanak, S Ketrangsri.   

Abstract

The role of naturally acquired circumsporozoite (CS) antibodies in protection against falciparum and vivax malaria was evaluated in a group of Thai endemic villagers using a prospective cohort and a case-control study design. There was no evidence of protection by either the presence of positive CS antibody levels at the presumed time of sporozoite exposure or in individuals who persistently had measurable levels of the antibodies. The study defined levels of CS antibodies that were not protective in natural infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2012264     DOI: 10.4269/ajtmh.1991.44.201

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  7 in total

Review 1.  Antigenic diversity and immune evasion by malaria parasites.

Authors:  Marcelo U Ferreira; Mônica da Silva Nunes; Gerhard Wunderlich
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

2.  Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic.

Authors:  Bryan Greenhouse; Benjamin Ho; Alan Hubbard; Denise Njama-Meya; David L Narum; David E Lanar; Sheetij Dutta; Philip J Rosenthal; Grant Dorsey; Chandy C John
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

3.  Seroreactivity with the Plasmodium falciparum blood stage antigen Pf332 in adults and children from malaria-endemic regions.

Authors:  J Iqbal; P Perlmann; B M Greenwood; K Berzins
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

4.  Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children.

Authors:  Chandy C John; Aaron J Tande; Ann M Moormann; Peter O Sumba; David E Lanar; Xinan M Min; James W Kazura
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

5.  Acquisition and Longevity of Antibodies to Plasmodium vivax Preerythrocytic Antigens in Western Thailand.

Authors:  Rhea J Longley; Arturo Reyes-Sandoval; Eduardo Montoya-Díaz; Susanna Dunachie; Chalermpon Kumpitak; Wang Nguitragool; Ivo Mueller; Jetsumon Sattabongkot
Journal:  Clin Vaccine Immunol       Date:  2015-12-09

Review 6.  Antibody Correlates of Protection from Clinical Plasmodium falciparum Malaria in an Area of Low and Unstable Malaria Transmission.

Authors:  Karen E S Hamre; Bartholomew N Ondigo; James S Hodges; Sheetij Dutta; Michael Theisen; George Ayodo; Chandy C John
Journal:  Am J Trop Med Hyg       Date:  2020-10-27       Impact factor: 3.707

Review 7.  Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis.

Authors:  Julia C Cutts; Rosanna Powell; Paul A Agius; James G Beeson; Julie A Simpson; Freya J I Fowkes
Journal:  BMC Med       Date:  2014-09-09       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.